1. Home
  2. CSBR vs AXR Comparison

CSBR vs AXR Comparison

Compare CSBR & AXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • AXR
  • Stock Information
  • Founded
  • CSBR 1985
  • AXR 1961
  • Country
  • CSBR United States
  • AXR United States
  • Employees
  • CSBR N/A
  • AXR N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • AXR Homebuilding
  • Sector
  • CSBR Health Care
  • AXR Real Estate
  • Exchange
  • CSBR Nasdaq
  • AXR Nasdaq
  • Market Cap
  • CSBR 135.5M
  • AXR 110.0M
  • IPO Year
  • CSBR 1986
  • AXR N/A
  • Fundamental
  • Price
  • CSBR $8.78
  • AXR $20.13
  • Analyst Decision
  • CSBR Strong Buy
  • AXR
  • Analyst Count
  • CSBR 1
  • AXR 0
  • Target Price
  • CSBR $12.00
  • AXR N/A
  • AVG Volume (30 Days)
  • CSBR 42.6K
  • AXR 19.7K
  • Earning Date
  • CSBR 03-11-2025
  • AXR 03-07-2025
  • Dividend Yield
  • CSBR N/A
  • AXR N/A
  • EPS Growth
  • CSBR N/A
  • AXR 472.07
  • EPS
  • CSBR 0.46
  • AXR 2.41
  • Revenue
  • CSBR $58,591,000.00
  • AXR $58,052,000.00
  • Revenue This Year
  • CSBR $14.19
  • AXR N/A
  • Revenue Next Year
  • CSBR $10.11
  • AXR N/A
  • P/E Ratio
  • CSBR $19.92
  • AXR $8.20
  • Revenue Growth
  • CSBR 19.03
  • AXR 30.35
  • 52 Week Low
  • CSBR $3.60
  • AXR $15.88
  • 52 Week High
  • CSBR $11.99
  • AXR $39.67
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 41.24
  • AXR 33.34
  • Support Level
  • CSBR $9.21
  • AXR $19.67
  • Resistance Level
  • CSBR $9.97
  • AXR $20.71
  • Average True Range (ATR)
  • CSBR 0.67
  • AXR 0.97
  • MACD
  • CSBR -0.07
  • AXR 0.16
  • Stochastic Oscillator
  • CSBR 13.66
  • AXR 32.58

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve the obtaining of approvals and the sale of both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

Share on Social Networks: